TITLE

CL 115,347, an Analogue of Prostaglandin E2

AUTHOR(S)
Cooke, E. D.; Bowcock, Sally A.; Watkins, C. J.; Rustin, M. H. A.; Kirby, J. D. T.
PUB. DATE
December 1985
SOURCE
Angiology;Dec1985, Vol. 36 Issue 12, p867
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The beneficial effects of intra-arterial or intravenous infusion of the prostanoid products of anachridonic acid, PGE and prostacyclin (PGI2) are well documented. More recently an analogue of PGE2, (CL 115,347, American Cynamid Co.) has become available. This substance is absorbed transdermally from a patch placed on the skin. In a placebo-controlled trial the vasodilatory effect of single incremental dosage, 500 mcg, 1000 mcg and 1500 mcg, was measured in a temperature/humidity controlled laboratory in normal subjects and in patients with primary and secondary Raynaud's phenomenon. The optimal dosage proved to be 1000 mcg; the effect may last for 84 hours; higher dosage may be associated with a ‘steal’ phenomenon.
ACCESSION #
16359818

 

Related Articles

  • Hyponatraemia and hypokalaemia during intravenous fluid administration. Armon, K.; Riordan, A.; Playfor, S.; Millman, G.; Khader, A. // Archives of Disease in Childhood;Apr2008, Vol. 93 Issue 4, p285 

    Background: Hospital-acquired hyponatraemia is associated with excessive volumes of hypotonic intravenous fluids and can cause death or permanent neurological deficit. Methods: A cross-sectional survey was carried out in 17 hospitals on all children receiving intravenous fluids during 1 day of a...

  • Reply to letter to the editor re: Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Nyman, Ulf; Almén, Torsten; Jacobsson, Bo; Aspelin, Peter // European Radiology;May2013, Vol. 23 Issue 5, p1264 

    A response from the authors of the article "Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?" is presented.

  • Letter to the Editor re: Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Stratta, Piero; Izzo, Cristina; Canavese, Caterina; Quaglia, Marco // European Radiology;May2013, Vol. 23 Issue 5, p1260 

    In a recent paper, the authors oppose the opinion that ' intra-arterial administration of iodinated-based contrast media (CM) appears to pose a greater risk of contrast-induced nephropathy (CIN) than intravenous administration' . As nephrologists, we are happy to have the opportunity to offer...

  • Pharmacokinetics of Deramciclane, a Novel Anxiolytic Agent, after Intravenous and Oral Administration. Huupponen, Risto; Paija, Outi; Salonen, Markku; Björklund, Harry; Rouru, Juha; Anttila, Markku // Drugs in R&D;2003, Vol. 4 Issue 6, p339 

    Background and objective: Deramciclane is a new compound that has shown anxiolytic effects in animal experiments and in human studies. The aim of this study was to determine the pharmacokinetic parameters of deramciclane after intravenous and oral administration, and its oral bioavailability....

  • Delivering intravenous therapy in the community setting. Sue O'Hanlon; Glenn, Ruth; Hazler, Belinda // Nursing Standard;4/9/2008, Vol. 22 Issue 31, p44 

    This article provides an overview of how an intravenous (IV) therapy service was developed in one primary care trust in England, the challenges that were faced and how they were overcome. The article includes some recommendations for others considering setting up a community IV therapy team.

  • Estimating the volume of prefilled bags of 5% dextrose injection. Newton, David W.; Peacock, Gina F.; Ballester, Angeles; Patif, David A. // American Journal of Health-System Pharmacy;6/15/2004, Vol. 61 Issue 12, p1281 

    Comments on strategies for determining the volume and contents of pre-filled bags of dextrose injections. Estimation of intravenous infusion at a constant rate to calculate accurate pharmacokinetic parameters; Precision of volume and weight data of the bags.

  • Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally. de Araújo, Cintia F.; Silva, Virgínia M. G.; Cronemberger-Andrade, Andre; Aragão-França, Luciana S.; Rocha, Viviane C. J.; Santos, Priscila S. L.; Pontes-de-Carvalho, Lain // BMC Research Notes;2014, Vol. 7 Issue 1, p1 

    Background It has been reported that repeated intravenous injections of a relatively large amount of Leishmania amazonensis amastigote extract (LaE) in BALB/c mice exacerbates the infection of these mice by Leishmania braziliensis. The identification of the extract active principle(s) through...

  • Variability in the concentrations of intravenous drug infusions prepared in a critical care unit. Wheeler, Daniel Wren; Degnan, Beverley Ann; Sehmi, Jobanpreet Singh; Burnstein, Rowan Margaret; Menon, David Krishna; Gupta, Arun Kumar // Intensive Care Medicine;Aug2008, Vol. 34 Issue 8, p1441 

    To quantify the variability in the concentration of drug infusions prepared on an intensive care unit and establish whether there was a relationship between the quality of syringe labeling and drug preparation. Audit carried out over 3 weeks in May 2006 and completed in May 2007. The adult...

  • Safe practice in intravenous medicines administration. Lavery, Irene; Ingram, Paula // Nursing Standard;7/23/2008, Vol. 22 Issue 46, p44 

    This article offers a practical guide on injecting medicines via the intravenous (IV) route, ensuring safe and effective practice. It considers the benefits of the IV route as well as possible hazards and complications. Through the assessment of risk, it outlines good practice standards.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics